Blog
Insights and Strategies To guide your LMI journey
Dr. Sandra (Sandy) Newes
Beyond Healing: Consciousness Expansion With Psychedelic Medicine
Dr. Keith Heinzerling, MD, is the Director of the Pacific Treatment and Research in Psychedelics (TRIP) program at the Pacific Neuroscience Institute, where he develops psychedelic-assisted therapies for conditions such as addiction, depression, anxiety, and PTSD. He is also an Internal Medicine and Addiction Medicine Specialist at the Pacific Brain...
Read MorePerspectives on Psychedelic Research, Clinical Trials, and Continuing To Connect From The Heart
Manish Agrawal, MD, is the Co-founder and CEO of Sunstone Therapies, the leader in the delivery of psychedelic-assisted therapies in the medical setting. Dr. Agrawal brings an extensive academic, clinical, and research background and depth of experience to Sunstone that spans medicine, engineering, philosophy, and ethics. Driven by a deep...
Read MoreA Mindfulness Expert Talks Psychedelics: Dr. Ron Siegel
Dr. Ron Siegel is an Assistant Professor of Psychology at Harvard Medical School, where he has taught for over 40 years. As a clinical psychologist in private practice, he has worked with low-income children and families, treated adults with chronic pain and stress disorders, and provided mindfulness-oriented psychotherapy. Dr. Siegel...
Read MoreExploring Psychedelic Sobriety With Dr. Rick Barnett
Dr. Rick Barnett is the Owner and Clinical Psychologist at BPS Health, LLC, a private online and in-person CBT practice. As the Co-founder of the Psychedelic Society of Vermont, he has been trained in psychedelic therapy and research, focusing on MDMA, psilocybin, and ketamine. Dr. Barnett is also an alcohol...
Read MoreWhat to Know: Advice for a Career in Ketamine-Assisted Psychotherapy
Dr. Signi Goldman, MD, is a board-certified psychiatrist and the Co-founder and Medical Director of Living Medicine Institute, which offers psychedelic-assisted psychotherapy training programs. As a certified provider for psychedelic-assisted therapy and research, she has practiced in various clinical settings, including hospital systems and alternative treatment settings. Dr. Goldman also...
Read MoreBreaking Barriers in Mental Health: How Psychedelic Therapy Can Reduce Human Suffering
Sherry Rais is the Co-founder and CEO of Enthea, a licensed, third-party administrator of health plan benefits. Through her company, she focuses on expanding access to psychedelic-assisted therapy to alleviate human suffering. Sherry holds a Certificate in Psychedelic Therapies and Research and is the former Executive Director of the Boston...
Read More